Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1045 of 6351
-
Proton beam plus chemo: a new hope for pancreatic cancer?
Disease control OngoingThe purpose of this study is to determine the maximum tolerated dose of the chemotherapy drugs nab-paclitaxel and gemcitabine when combined with hypofractionated ablative proton therapy for the treatment of locally advanced pancreatic cancer. You will receive proton therapy once …
Phase 1/2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can one spinal injection cut opioid use after chest surgery?
Symptom relief CompletedThoracotomy is associated with some of the most severe postoperative pain of any surgical procedure. Inadequate analgesia restricts inspiratory effort and impairs the ability to cough, predisposing patients to atelectasis, retained secretions and pneumonia, delaying mobilisation,…
Sponsor: Bursa City Hospital • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
New drug cocktail shows promise for tough lung cancer
Disease control CompletedThis phase I/II trial studies the best dose of selumetinib and how well it works with durvalumab and tremelimumab in treating participants with stage IV non-small cell lung cancer or that has come back. Immunotherapy with monoclonal antibodies, such as durvalumab and tremelimumab…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New combo therapy aims to tackle tough pancreatic cancer
Disease control CompletedThe prognosis of pancreatic cancer is extremely poor. Current guidelines recommend FOLFIRINOX or modified-FOLFIRINOX as the first-line chemotherapeutic regimen. Studies have shown that immunotherapy with Anti-PD-1 antibody can effectively increase the response rate and prolong pa…
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Breath of fresh air: new MRI could spot lung rejection before It's too late
Diagnosis Recruiting nowLung transplantation (LT) is the only definitive therapy for many patients with end-stage lung diseases. The supply of donors' lungs is the biggest bottleneck to performing a lung transplant, and many patients die while waiting. Acute Cellular Rejection (ACR) is a significant ris…
Phase 2 • Sponsor: University of Virginia • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Common heart drug may stop deadly bleeding in liver patients
Disease control OngoingResearch has proven that large varices can be treated with beta-blockers (a type of anti-hypertensive medication) to reduce the pressure in the veins. The management of small varices is still uncertain. This study aims to discover if beta blockers can be used in this setting. We …
Phase 4 • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New pill shows promise in shrinking MS brain lesions
Disease control CompletedPrimary Objective: To determine the dose-response relationship for SAR442168 to reduce the number of new active brain lesions. Secondary Objectives: * To evaluate efficacy of SAR442168 on disease activity as assessed by imaging measures. * To evaluate the safety and tolerabili…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:17 UTC
-
New drug combo aims to extend life in tough colorectal cancer
Disease control OngoingPatients with metastatic colorectal cancer (mCRC) who have received all approved standard treatments (except Regorafenib and Lonsurf) no longer have treatment options available while maintaining a good performance status which would allow them to receive a new treatment
Phase 3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New oral pill aims to fight RSV in adults
Disease control Stopped earlyThis is a randomised, double-blind, placebo-controlled, multicentre, phase 2 study to evaluate the efficacy, safety and tolerability of orally administered AK0529 in Chinese adults with RSV infection.
Phase 2 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a simple mineral calm the stress of fibromyalgia?
Symptom relief CompletedFibromyalgia affects an average of 2% of the French population. Data from the literature report that low levels of magnesium could be associated with fibromyalgia. However, no study to date has investigated the effect of oral magnesium administration on stress in fibromyalgia. T…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a lung drug stop transplant rejection? new trial tests Alpha-1 antitrypsin for GVHD
Disease control Stopped earlyThis study is a phase 2 / 3 prospective, double-blind, randomized, multicenter, placebo-controlled study for prevention of acute GVHD (aGVHD) in participants undergoing an unrelated (matched or single allele mismatched) or matched related allogeneic hematopoietic cell transplanta…
Phase 2/3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Immune drug shows promise against tough brain cancers
Disease control OngoingBackground: Gliomas are the most common malignant brain tumors. Some have certain changes (mutations) in the genes isocitrate dehydrogenase 1 (IDH1) or isocitrate dehydrogenase 2 (IDH2). If there are a high number of mutations in a tumor, it is called hypermutator phenotype (HMP…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New eye on pancreatic cancer: Ultra-High resolution OCT could catch tumors at micrometer scale
Diagnosis Recruiting nowThis trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic c…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Inhaled cyclosporine aims to halt lung transplant rejection
Disease control CompletedThe objective of this trial was to assess the efficacy and safety of aerosolized liposomal cyclosporine A (L-CsA) as add-on therapy to standard of care (SoC) as compared to SoC alone in double lung transplant (DLT) recipients with chronic lung allograft dysfunction (CLAD)-bronchi…
Phase 3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could removing catheters sooner after kidney transplant cut infections?
Disease control OngoingThe purpose of this study is to compare frequency of UTI, urine leak and need for reoperation in patients after renal transplant with early or delayed Foley catheter removal. The hypothesis of the ELUCATR trial is that there is no need to keep Foley catheter longer than 24 hours …
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo aims to outsmart Drug-Resistant leukemia
Disease control OngoingThis phase II trial studies how well venetoclax and ibrutinib work in treating participants with chronic lymphocytic leukemia and have developed genetic mutations after previously being treated with ibrutinib. Venetoclax and ibrutinib may stop the growth of cancer cells by blocki…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a VR headset replace pills for surgery anxiety?
Symptom relief OngoingIn the perioperative setting, distraction therapies have been used as a technique to reduce anxiety and pain in the perioperative period. Measures employed in the local restructured hospitals include television, magazines, and newspapers. Tablet-based activity, music and video di…
Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Inhaled cyclosporine shows promise for lung transplant rejection
Disease control CompletedThe objective of this trial is to assess the efficacy and safety of aerosolized liposomal cyclosporine A (L-CsA) as add-on therapy to standard of care (SoC) as compared to SoC alone in single lung transplant recipients with chronic lung allograft dysfunction (CLAD)-bronchiolitis …
Phase 3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for native youth: study tests best ways to prevent suicide
Disease control Completed1. To use a SMART design to evaluate which of four sequences of New Hope (NH), Elders Resilience (ER) and Case Management (CM) have the greater effects on immediate and longer-term suicidal ideation (primary outcome) and resilience (secondary outcome) among American Indian (AI) a…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can CML patients pause treatment? new study explores Drug-Free remission
Disease control Stopped earlyThis study is constituted of two stage: Treatment-Free Remission 1 (TFR1) stage and Treatment-Free Remission 2 (TFR2) stage. The purpose of the TFR1 stage is to assess the effect of nilotinib reduced to half the standard dose for 12 months on treatment-free remission in patients…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC